Genetic Dissimilarity of Two Fluconazole-resistant Candida Albicans Strains Causing Meningitis and Oral Candidiasis in the Same AIDS Patient

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 1996 Jun 1

PMID 8735114

Citations 10

Authors

J Berenguer

T M Diaz-Guerra

J C Bernaldo De Quiros

J L Rodriguez-Tudela

J V Martinez-Suarez

Affiliations

Soon will be listed here.

Abstract

We describe a patient with AIDS who simultaneously developed Candida meningitis with three positive cerebrospinal fluid cultures and oral candidiasis. This patient also had a history or recurrent episodes of oral candidiasis treated with fluconazole. The patient did not respond to this therapy but was cured with amphotericin B and flucytosine. In vitro susceptibility tests revealed that each infection was caused by fluconazole-resistant Candida albicans isolates. Strain delineation by karyotyping, NotI restriction pattern analysis, hybridization with the specific probe 27A, and PCR fingerprinting with the phage M13 core sequence clearly demonstrated that meningitis and oral thrush were caused by two genetically different isolates.

Citing Articles

Use of checkerboard assay to determine the synergy between essential oils extracted from leaves of (L.) Correa and nystatin against .

Kamble P, Phadke M Ayu. 2024; 44(1):38-43.

PMID: 38505112 PMC: 10946663. DOI: 10.4103/ayu.ayu_397_21.

Survey of the Antibiofilm and Antimicrobial Effects of Zingiber officinale (in Vitro Study).

Aghazadeh M, Zahedi Bialvaei A, Aghazadeh M, Kabiri F, Saliani N, Yousefi M Jundishapur J Microbiol. 2016; 9(2):e30167.

PMID: 27127591 PMC: 4842230. DOI: 10.5812/jjm.30167.

Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode.

Vargas K, Messer S, Pfaller M, Lockhart S, Stapleton J, Hellstein J J Clin Microbiol. 2000; 38(10):3595-607.

PMID: 11015370 PMC: 87443. DOI: 10.1128/JCM.38.10.3595-3607.2000.

The ins and outs of DNA fingerprinting the infectious fungi.

Soll D Clin Microbiol Rev. 2001; 13(2):332-70.

PMID: 10756003 PMC: 100156. DOI: 10.1128/CMR.13.2.332.

High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance.

Yoon S, Vazquez J, Steffan P, Sobel J, Akins R Antimicrob Agents Chemother. 1999; 43(4):836-45.

PMID: 10103188 PMC: 89214. DOI: 10.1128/AAC.43.4.836.

References

Pfaller M . Epidemiology of fungal infections: the promise of molecular typing. Clin Infect Dis. 1995; 20(6):1535-9. DOI: 10.1093/clinids/20.6.1535. View

Berenguer J, Fernandez-Baca V, Sanchez R, Bouza E . In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infections. Eur J Clin Microbiol Infect Dis. 1995; 14(4):362-5. DOI: 10.1007/BF02116535. View

Rodriguez-Tudela J, Martinez-Suarez J . Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria. J Antimicrob Chemother. 1995; 35(6):739-49. DOI: 10.1093/jac/35.6.739. View

Rodriguez-Tudela J, Martinez-Suarez J, Dronda F, Laguna F, Chaves F, Valencia E . Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients. J Antimicrob Chemother. 1995; 35(6):793-804. DOI: 10.1093/jac/35.6.793. View

Martinez-Suarez J, Rodriguez-Tudela J . Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain. Antimicrob Agents Chemother. 1995; 39(7):1512-6. PMC: 162772. DOI: 10.1128/AAC.39.7.1512. View

Espinel-Ingroff A, Rodriguez-Tudela J, Martinez-Suarez J . Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans. J Clin Microbiol. 1995; 33(12):3154-8. PMC: 228663. DOI: 10.1128/jcm.33.12.3154-3158.1995. View

KANTOR H, Emsellem H, Hogg J, Simon G . Candida albicans meningitis in a parenteral drug abuser. South Med J. 1984; 77(3):404-5. DOI: 10.1097/00007611-198403000-00040. View

Smego Jr R, Perfect J, Durack D . Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis. Rev Infect Dis. 1984; 6(6):791-801. DOI: 10.1093/clinids/6.6.791. View

Vassart G, Georges M, Monsieur R, Brocas H, Lequarre A, Christophe D . A sequence in M13 phage detects hypervariable minisatellites in human and animal DNA. Science. 1987; 235(4789):683-4. DOI: 10.1126/science.2880398. View

10.

Ehni W, Ellison 3rd R . Spontaneous Candida albicans meningitis in a patient with the acquired immune deficiency syndrome. Am J Med. 1987; 83(4):806-7. DOI: 10.1016/0002-9343(87)90926-0. View

11.

Scherer S, Stevens D . A Candida albicans dispersed, repeated gene family and its epidemiologic applications. Proc Natl Acad Sci U S A. 1988; 85(5):1452-6. PMC: 279789. DOI: 10.1073/pnas.85.5.1452. View

12.

Soll D, Staebell M, Langtimm C, Pfaller M, Hicks J, Rao T . Multiple Candida strains in the course of a single systemic infection. J Clin Microbiol. 1988; 26(8):1448-59. PMC: 266641. DOI: 10.1128/jcm.26.8.1448-1459.1988. View

13.

Polak A . Combination therapy with antifungal drugs. Mycoses. 1988; 31 Suppl 2:45-53. View

14.

Soll D, Galask R, Schmid J, Hanna C, Mac K, Morrow B . Genetic dissimilarity of commensal strains of Candida spp. carried in different anatomical locations of the same healthy women. J Clin Microbiol. 1991; 29(8):1702-10. PMC: 270187. DOI: 10.1128/jcm.29.8.1702-1710.1991. View

15.

. AIDS presenting as Candida albicans meningitis: a case report. AIDS. 1991; 5(10):1268-9. DOI: 10.1097/00002030-199110000-00022. View

16.

Lyman C, Walsh T . Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications. Drugs. 1992; 44(1):9-35. DOI: 10.2165/00003495-199244010-00002. View

17.

Francis P, Walsh T . Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy. Clin Infect Dis. 1992; 15(6):1003-18. DOI: 10.1093/clind/15.6.1003. View

18.

Bisbe J, Miro J, Latorre X, Moreno A, Mallolas J, Gatell J . Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review. Clin Infect Dis. 1992; 15(6):910-23. DOI: 10.1093/clind/15.6.910. View

19.

Schmid J, Rotman M, Reed B, Pierson C, Soll D . Genetic similarity of Candida albicans strains from vaginitis patients and their partners. J Clin Microbiol. 1993; 31(1):39-46. PMC: 262617. DOI: 10.1128/jcm.31.1.39-46.1993. View

20.

Powderly W, Robinson K, Keath E . Molecular epidemiology of recurrent oral candidiasis in human immunodeficiency virus-positive patients: evidence for two patterns of recurrence. J Infect Dis. 1993; 168(2):463-6. DOI: 10.1093/infdis/168.2.463. View